American Family and Cox Enterprises have helped the digital insurance provider reach a unicorn valuation and take its overall funding to $329m.

Vision Fund 2 participated in a series B round for the gene therapy developer, formed through the 2019 merger of Torque Therapeutics and Cogen Immune Medicine.

Vizgen co-founder David Walt, a professor at Harvard Medical School, has invested in the spinout as part of its series B round.

Gene therapy developer Jaguar has completed a series B round co-led by Eli Lilly and Deerfield Management.

Esri helped Allied Minds' satellite constellation operator take its total funding to $155m in a round that will fund the launch of more satellites.

ECBF has provided an extension for the pesticide and crop stimulant provider's Group De Ceuster-bacekd series B round, which now stands at $21.8m.

UVC Partners has led a $21m series B round for Wire.

SafeGuard Cyber has raised $45m in a Cisco-backed debt and equity round while Pine Labs has paid the same amount to buy portfolio company Fave.

The personalised dental care provider increased its overall funding to almost $200m in a GV-backed series C round.

The drug discovery platform developer will support its growth with new funding from investors including SIG and Legend Capital.